Clinical Trial Update: Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the effects of angiotensin II receptor blockers and ACE inhibitors on silent brain infarction and cognitive decline; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Stroke

Snippet

Sponsor: Nara Medical University | Conditions: Brain Infarction, Hypertension | Phase 4 | Status: COMPLETED